|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| C12N 15/13 | |||
| A61P 5/06 | |||
| A61P 9/10 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3133084 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16178026.7 |
| Europos patento paraiškos padavimo data | 2007-09-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 843430 P | 2006-09-08 | US | |
| 956653 P | 2007-08-17 | US |
| (72) |
HAN, Hq, US
CHEN, Qing, US
KWAK, Keith Soo-Nyung, US
ZHOU, Xiaolan, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF |
| ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF |